Avinger (NASDAQ:AVGR) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Avinger (NASDAQ:AVGRFree Report) in a research report report published on Saturday morning. The firm issued a hold rating on the medical device company’s stock.

Avinger Stock Performance

Shares of AVGR opened at $0.47 on Friday. The business has a 50-day moving average of $0.64 and a 200 day moving average of $0.84. Avinger has a fifty-two week low of $0.36 and a fifty-two week high of $5.45. The firm has a market cap of $1.57 million, a P/E ratio of -0.04 and a beta of 1.09.

About Avinger

(Get Free Report)

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.

See Also

Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.